Highest-materiality recent filing
Pyxus Q4 sales up 35% YoY; full-year record adjusted EBITDA of $226.7M
Q4 net sales $678.2M (+35.2% YoY); gross profit $94.4M (+40.4%).
Pyxus Q3 net income $16.9M; reaffirms FY2026 guidance for $2.4-2.6B sales
Q3 sales $655.8M (down 15.7% YoY) due to timing of shipments in Africa/Europe and lower pricing.
Q2 sales $570.2M (+0.7% YoY); operating income $46.7M (vs $33.0M); net loss $0.9M (vs $3.2M loss).
Pyxus Q1 fiscal 2026 sales $508.8M (-19.8% YoY), net loss $15.8M; full-year guidance unchanged
Revenue $508.8M vs $634.9M YoY; gross margin 12.9% vs 13.2% on mix shift.
Pyxus reports FY2025 revenue up 22.1% to $2.5B, net income $15.2M, issues FY2026 guidance
Revenue $2.5B (+22.1% YoY) driven by 18% price/kg increase and 3.4% volume growth.
Credit facility increased by $30M from $120M to $150M.
CFO resigns effective Feb 28, 2025; interim successor appointed
CFO Flavia B. Landsberg resigns effective Feb 28, 2025 to accept employment elsewhere.
Pyxus Q3 revenue up 47% to $778M, net income $18.9M; raises FY guidance
Revenue $778.3M (+46.9% YoY); net income $18.9M vs $3.8M in prior year.
Pyxus Q2 fiscal 2025 revenue $566.3M (-9.3% YoY), net loss $3.2M; raises full-year guidance
Q2 revenue $566.3M vs $624.3M YoY; volume down 23%, price up 14.5%.
Pyxus reports strong Q1 FY25: sales $634.9M (+33%), net income $4.6M, debt repurchase $122.5M
Sales grew 33.1% to $634.9M driven by 16.9% price increase and 11.9% volume growth.
Pyxus reports FY2024 net income $2.7M, revenue $2.0B, debt repurchase on track
Net income of $2.7M vs prior year loss of $39.1M; operating income $137.2M (+46.3% YoY).
Pyxus repurchases $112M in notes at 23% discount; expects $142.9M total debt reduction
Repurchased $78M principal of 8.5% Senior Secured Notes due 2027 for $60M cash (23% discount to par).
Pyxus reports Q3 net income $3.8M vs loss $2.3M YoY; raises FY adjusted EBITDA guidance to $185-195M
Q3 net income of $3.8M versus net loss of $2.3M in prior-year quarter; operating income up 14.9% to $47.8M.
Pyxus Q2 revenue up 22.8% to $624.3M, net income $8.1M, raises FY2024 guidance
Revenue $624.3M (+22.8% YoY) driven by 10.2% volume increase and 11.7% higher average prices.
Pyxus Q1 revenue up 39% to $477M, net income $0.8M; maintains FY24 guidance
Sales $477.1M (+38.7% YoY); operating income $36.4M vs $7.0M.
Sales and other revenues $1,914.9M (+16.8% YoY); net loss $39.1M, improving $43.0M from prior year.
Pyxus extends ABL credit facility maturity to Feb 8, 2027 via second amendment
Pyxus Holdings and its subsidiaries as borrowers, with Pyxus International as guarantor, entered Second Amendment to ABL Credit Agreement on May 23, 2023.
Pyxus Q3 sales up 53% to $655.6M; revises FY23 guidance higher
Net loss improved to $2.3M from $30.1M YoY; operating income up 38% to $41.6M.
Pyxus completes debt exchange; extends maturities to Dec 2027, issues $580M new debt
Exchanged 100% of DDTL facility loans and exit facility loans; ~92.7% of existing 10% notes exchanged for new 8.50% notes due 2027.
Pyxus exchange offer: 92.74% of 10% notes tendered for new 8.5% notes due 2027
$260.5M of $281M outstanding existing notes tendered (92.74% participation).
Pyxus subsidiary commences exchange offer for 10% notes due 2024 to new 8.5% notes due 2027
Pyxus Holdings offers to exchange all $280.8M outstanding 10% Senior Secured First Lien Notes due 2024 for new 8.5% Senior Secured Notes due 2027 at par.
Pyxus signs Support Agreement to exchange 99.7% DDTL, 68% Exit loans, 64% notes for new 2027 debt
Supporting holders hold 99.7% of DDTL Facility Loans, 68.1% of Exit Facility Loans, 64.1% of Existing Notes.
Pyxus Q2 sales up 29% to $508.3M; net loss narrows to $1.5M; maintains FY guidance
Sales rose 28.9% to $508.3M, driven by 17.5% higher leaf volume and 13.3% higher avg price per kilo.
Pyxus Q1 FY2023 revenue up 3.2% to $343.9M; net loss widens to $14.7M; reaffirms FY guidance
Sales $343.9M (+3.2% YoY); net loss $14.7M (up $3.2M) on lower tax benefit.
Pyxus reports fiscal 2022 revenue up 23% to $1.64B, adjusted EBITDA rises 36% to $126.7M
Sales and other operating revenues of $1,639.9M, up 23.1% YoY; gross margin improved to 13.8%.
Pyxus subsidiary enters $100M term loan amendment, extends maturity to Dec 2023
Intabex Netherlands B.V. amended its term loan credit agreement to a $100M facility from existing lenders Glendon, Monarch, and Owl Creek.
Pyxus Q3 revenue up 13% to $428.9M; exits cannabis ops; new $100M ABL
Sales $428.9M (+13.0% YoY); gross profit $65.2M (+4.3%); SG&A down 25.5% to $34.2M.
Pyxus enters $100M ABL credit facility with PNC, refinances existing debt
New $100M ABL facility ($20M accordion to $120M) matures Feb 8, 2027; BSBY+300bps or base+200bps.
Pyxus appoints Flavia Landsberg as CFO effective after Q3 10-Q filing; Joel Thomas retires
Flavia Landsberg named EVP and CFO, effective immediately after SEC filing of Form 10-Q for Sep 30, 2021.
Pyxus Q2 revenue up 30% to $394M but swings to net loss; shipping delays weigh
Revenue increased 30.3% to $394.2M; gross margin improved to 13.2% from 11.8%.
Pyxus Q1 sales +26.8% to $333.3M; net loss improves 87.5% to $11.5M; adj. EBITDA $14.8M (+92.2%)
Sales $333.3M vs $262.8M YoY; leaf volume +8.6%, avg price +17.4%.
On June 12, 2025, the Company's Board of Directors designated Christopher G. Meredith, the Company's Corporate Controller, as the Company's principal accounting officer, effective on June 27, 2025.
On June 11, 2025, Philip C. Garofolo, Senior Vice President Finance and Chief Accounting Officer of Pyxus International, Inc. (the "Company"), resigned from his positions with the Company effective June 27, 2025 to accept employment with another company.
On February 12, 2025, Flavia B. Landsberg, Executive Vice President and Chief Financial Officer of Pyxus International, Inc. (the "Company"), resigned from her positions with the Company effective February 28, 2025 to accept employment with another company.
On February 13, 2025, the Company’s Board of Directors appointed Dustin L. Styons, Executive Vice President, Business Strategy & Sales of the Company, as the Company’s Interim Chief Financial Officer, effective on February 28, 2025.
On September 12, 2023 , the Board of Directors of Pyxus International, Inc. (the "Company") appointed Scott A. Burmeister as Executive Vice President and Chief Operating Officer of the Company and Dustin L. Styons as Executive Vice President, Business Strategy & Sales of the Company.
On September 12, 2023 , the Board of Directors of Pyxus International, Inc. (the "Company") appointed Scott A. Burmeister as Executive Vice President and Chief Operating Officer of the Company and Dustin L. Styons as Executive Vice President, Business Strategy & Sales of the Company.
Patrick B. Fallon, a member of the Board of Directors of Pyxus International, Inc. (the “Company”), resigned as a director of the Company effective on January 18, 2023.
On January 18, 2023, the Board of Directors of the Company increased the size of the Board of Directors from six to seven and elected John S. Alphin and Patrick J. Bartels, Jr. as directors to fill the vacancies created by the increase in the size of the Board of Directors and Mr. Fallon’s resignation.
On January 18, 2023, the Board of Directors of the Company increased the size of the Board of Directors from six to seven and elected John S. Alphin and Patrick J. Bartels, Jr. as directors to fill the vacancies created by the increase in the size of the Board of Directors and Mr. Fallon’s resignation.
On October 19, 2022, the Board of Directors of the Company elected Jamie J. Ashton as a director to fill the vacancy created by Ms. Kim’s resignation.
On October 17, 2022, Holly Kim, a member of the Board of Directors of Pyxus International, Inc. (the “Company”), resigned as a director of the Company effective on October 19, 2022.
On April 29, 2022, Carl L. Hausmann, a director of Pyxus International, Inc. (the “Company”), communicated to the Company his intention to retire as a director when his current term expires at the 2022 annual meeting of shareholders.
Max materiality 0.85 · Median 0.65 · Most common event earnings